APPLICATION
ANDA206452
TYPE
ANDA
ORIGINAL APPROVAL
2023-07-12
LATEST ACTION
2025-04-30
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued
Products
PREGABALINDiscontinued
PREGABALIN 225MG · CAPSULE · ORAL
PREGABALINDiscontinued
PREGABALIN 150MG · CAPSULE · ORAL
PREGABALINDiscontinued
PREGABALIN 75MG · CAPSULE · ORAL
PREGABALINDiscontinued
PREGABALIN 25MG · CAPSULE · ORAL
PREGABALINDiscontinued
PREGABALIN 300MG · CAPSULE · ORAL
PREGABALINDiscontinued
PREGABALIN 200MG · CAPSULE · ORAL
PREGABALINDiscontinued
PREGABALIN 100MG · CAPSULE · ORAL
PREGABALINDiscontinued
PREGABALIN 50MG · CAPSULE · ORAL
Approval history
2025-04-30Labeling · Supplement 1 · standardAP
2023-07-12UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.